Partner Headlines - IRWD

  1. Ironwood Pharmaceuticals Announces $150M Proposed Public Offering ...

    Benzinga
  2. Mid-Day Market Update: Dow Tumbles Over 100 Points; Signature ...

    Benzinga
  3. Mid-Morning Market Update: Markets Mixed; Verizon Posts Q4 Profit

    Benzinga
  4. Weekly 3-Year Low Highlight: EXC, RVBD, IRWD, SHOS

    GuruFocus
  5. UPDATE: Cowen & Company Upgraded Ironwood Pharmaceuticals

    Benzinga
  6. Five-Year Lows: Singapore Airlines Limited, Gold Field Ltd., ...

    GuruFocus
  7. Stocks Hitting 52-Week Lows

    Benzinga
  8. Earnings Scheduled For January 15, 2013

    Benzinga
  9. Ironwood Starts Phase I Trial of Anti-Anxiety Drug in US

    Benzinga
  10. Weekly CEO Buys Highlight: GDOT, VOCS, PES, IRWD, ABR

    GuruFocus
  11. Ironwood Pharmaceuticals, Inc. (IRWD) CEO Peter M Hecht buys ...

    GuruFocus
  12. Ironwood and AstraZeneca Announce Linaclotide Collaboration for ...

    Benzinga
  13. Ironwood and Forest Announce FDA Approval of LINZESSTM

    Benzinga
  14. UPDATE: Cantor Fitzgerald Raises PT to $8 on Ironwood Pharmaceuticals; ...

    Benzinga
  15. Biotechs With Upcoming PDUFA Dates

    Benzinga
  16. UPDATE: Wedbush Downgrades Ironwood Pharmaceuticals; Lowers PT

    Benzinga
  17. Bank of America: Zelnorm vs. linaclotide

    Benzinga
  18. Ironwood Pharmaceuticals Announces Exercise of Over-Allotment ...

    Benzinga
  19. From Earlier: Ironwood Pharmaceuticals Prices Public Offering ...

    Benzinga
  20. Ironwood Pharmaceuticals Announces Proposed Public Offering of ...

    Benzinga
  21. Ironwood Pharmaceuticals and Bionomics Announce Collaboration, ...

    Benzinga
  22. European Patent Office Upholds Synergy Pharmaceuticals' Grant ...

    Benzinga
Trading Center